Abstract:Transgenic mice expressing human cholesteryl ester transfer protein (HuCETPTg mice) were crossed with apolipoprotein CI-knocked out (apoCI-KO) mice. Although total cholesterol levels tended to be reduced as the result of CETP expression in HuCETPTg heterozygotes compared with C57BL6 control mice (-13%, not significant), a more pronounced decrease (-28%, p < 0.05) was observed when human CETP was expressed in an apoCI-deficient background (HuCETPTg/apoCI-KO mice). Gel permeation chromatography analysis revealed a significant, 6.1-fold rise (p < 0.05) in the cholesteryl ester content of very low density lipoproteins in HuCETPTg/apoCI-KO mice compared with control mice, whereas the 2.7-fold increase in HuCETPTg mice did not reach the significance level in these experiments. Approximately 50% decreases in the cholesteryl ester content and cholesteryl ester to triglyceride ratio of high density lipoproteins (HDL) were observed in HuCETPTg/apoCI-KO mice compared with controls (p < 0.05 in both cases), with intermediate -20% changes in HuCETPTg mice. The cholesteryl ester depletion of HDL was accompanied with a significant reduction in their mean apparent diameter (8.68 +/- 0.04 nm in HuCETPTg/apoCI-KO mice versus 8.83 +/- 0.02 nm in control mice; p < 0.05), again with intermediate values in HuCETPTg mice (8.77 +/- 0.04 nm). In vitro purified apoCI was able to inhibit cholesteryl ester exchange when added to either total plasma or reconstituted HDL-free mixtures, and coincidently, the specific activity of CETP was significantly increased in the apoCI-deficient state (173 +/- 75 pmol/microg/h in HuCETPTg/apoCI-KO mice versus 72 +/- 19 pmol/microg/h in HuCETPTg, p < 0.05). Finally, HDL from apoCI-KO mice were shown to interact more readily with purified CETP than control HDL that differ only by their apoCI content. Overall, the present observations provide direct support for a potent specific inhibition of CETP by plasma apoCI in vivo.

Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.

Apolipoprotein Ci Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (cetp) in Cetp Transgenic/Apoci-Knocked out Mice

Cholesteryl Ester Transfer Protein (CETP) Expression Enhances HDL Cholesteryl Ester Liver Delivery, Which is Independent of Scavenger Receptor BI, LDL Receptor Related Protein and Possibly LDL Receptor

Cholesteryl Ester Transfer Protein Modulates the Effect of Liver X Receptor Agonists on Cholesterol Transport and Excretion in the Mouse

Adipose Tissue Specific Cetp Expression in Mice: Impact on Plasma Lipoprotein Metabolism

Reduced High Density Lipoprotein Cholesterol in Human Cholesteryl Ester Transfer Protein Transgenic Mice.

Down-regulation of Mrna for the Low Density Lipoprotein Receptor in Transgenic Mice Containing the Gene for Human Cholesteryl Ester Transfer Protein. Mechanism to Explain Accumulation of Lipoprotein B Particles.

Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels.

Comparative Studies of Three Cholesteryl Ester Transfer Proteins and Their Interactions with Known Inhibitors

The Lipid Transfer Properties of CETP Define the Concentration and Composition of Plasma Lipoproteins.

Both full length-cholesteryl ester transfer protein and exon 9-deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes

Human cholesteryl ester transport protein transgene promotes macrophage reverse cholesterol transport in C57BL/6 mice and phospholipid transfer protein gene knockout mice

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

Abstract 1025: Importance of Macrophage Cholesteryl Ester Transfer Protein (CETP) for Determining Serum Cholesteryl Ester Transfer Activity and Atherosclerosis

Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression

The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes

Simultaneous Determination of Biliary and Intestinal Cholesterol Secretion Reveals That CETP (Cholesteryl Ester Transfer Protein) Alters Elimination Route in Mice

Cholesteryl Ester Transfer Protein Impairs Triglyceride Clearance via Androgen Receptor in Male Mice

HDL from CETP-deficient Subjects Shows Enhanced Ability to Promote Cholesterol Efflux from Macrophages in an Apoe- and ABCG1-dependent Pathway.

Exon 9-deleted CETP inhibits full length-CETP synthesis and promotes cellular triglyceride storage

Apolipoprotein F: a Natural Inhibitor of Cholesteryl Ester Transfer Protein and a Key Regulator of Lipoprotein Metabolism